PTPA and cancer: Other than the conventional theory that tamoxifen affects cancer cell survival through estrogen receptor antagonism, our previous study showed that tamoxifen also exerts an “off-target” mechanism of apoptosis induction via the inhibition of CIP2A, an oncogenic cellular inhibitor of PP2A in ER-negative breast cancer cells [21].